**Core tip:** Simultaneous occurrence of multiple tumors is rare. This article reports a patient who was admitted to hospital with hypercalcemia and finally diagnosed with a parathyroid adenoma *via* surgical pathology. The patient also had uterine fibroids, benign mammary gland tumor, and meningioma. After diagnosis, these tumors were all removed.

INTRODUCTION
============

A single person with tumors occurring in multiple organs is rare. Endocrine tumor refers to a series of tumors that not only has the characteristics of a tumor but also has endocrine function. Based on its endocrine function, it can be divided into functional and non-functional.

Here, we report the case of a patient with tumors in multiple organs. Among these, only the parathyroid tumor had endocrine function. Therefore, we postulated that the patient was genetically heterogeneous, which would lead to the emergence of such multiple types of tumors.

CASE PRESENTATION
=================

Chief complaints
----------------

A 39-year-old woman attended a local hospital due to abdominal distension, abdominal pain with asthenia, and anorexia.

History of present illness
--------------------------

After abdominal subtotal hysterectomy for multiple myomata of uterus, the patient experienced recurrent abdominal pain and distension. During the next 10 d, these symptoms gradually worsened.

History of past illness
-----------------------

She underwent surgery for a meningeal tumor 4 years ago and resection of a right breast benign tumor 6 mo ago. After subtotal hysterectomy, the patient developed an epileptic seizure in the anesthetic recovery room.

Physical examination upon admission
-----------------------------------

Physical examination on admission revealed blood pressure of 15.8/10.7 mmHg, resting pulse of 90 times/min, body mass index of 22.4 kg/m^2^, and tenderness beneath the xiphoid process.

Laboratory examinations
-----------------------

Laboratory tests showed increased calcium 4.21 mmol/L, depressed phosphorus 0.85 mmol/L, and elevated urine calcium 8.32 mmol/24 h (reference range 2.50-7.50). The plasma level of parathyroid hormone (PTH) was elevated to 492.00 pg/mL (reference range 10.00-69.00). A diagnosis of hyperparathyroidism was established. Her sex hormone levels were normal, serum 25-hydroxyvitamin D concentration was decreased to 7.0 ng/mL (normal range 30-100), and serum calcitonin was 5.62 pg/mL (normal level \< 11.5).

Imaging examinations
--------------------

A neck ultrasound showed a right thyroid solid nodule that measured 3.3 × 2.8 mm, and fine needle aspiration revealed normal thyroid tissues. A parathyroid left inferior thyroid lobe nodule of 26 mm × 34 mm was discovered *via* parathyroid B- ultrasound and enhanced computed tomography scan. A 99 mTc-MIBI parathyroid imaging study was performed and showed elevated levels of radiation in the site of left inferior thyroid, which was considered as a parathyroid adenoma (Figure [1](#F1){ref-type="fig"}). Bone X-ray examination of the skull and whole extremities revealed no osteopenia, but bone mineral density indicated lumbar L1-4 and upper femur osteopenia. Based on the above findings, the diagnosis of primary hyperparathyroidism due to parathyroid tumor was considered.

![Radionuclide imaging of parathyroid glands.](WJCC-7-3132-g001){#F1}

FINAL DIAGNOSIS
===============

The patient was diagnosed with primary hyperparathyroidism, left parathyroid adenoma, right thyroid adenoma, right benign mammary gland tumors and meningioma.

TREATMENT
=========

This patient received fluid replacement and calcitonin after admission. The patient underwent parathyroidectomy and the pathology revealed a parathyroid adenoma (Figure [2](#F2){ref-type="fig"}). The patient had undergone resection of several tumors previously, however, we only obtained the pathological picture of a meningioma (Figure [3](#F3){ref-type="fig"}).

![Pathological examination revealed a parathyroid adenoma. A: PTH-1, × 100; B: TG-1, × 200; C: Ki-67-2, × 200; D: CK19-1, × 200.](WJCC-7-3132-g002){#F2}

![Pathological examination revealed a meningioma (× 200).](WJCC-7-3132-g003){#F3}

OUTCOME AND FOLLOW-UP
=====================

The serum calcium after surgery was normal. She had recovered well after para-thyroid surgery, and her post-operative course was uneventful. Her thyroid adenoma had received routine follow-up. After myomectomy, she had not followed up recently by B-ultrasonography. In March this year, the meningioma recurred again and the patient was hospitalized.

DISCUSSION
==========

Hyperparathyroidism involves a variety of clinical manifestations\[[@B1]\]. Skeletal symptoms mainly manifested as bone pain in the early stage\[[@B2]\]. In the late stage, skeletal malformations and pathologic fracture gradually appear, and patients even develop skull brown tumors of hyperparathyroidism\[[@B3]\]. This case mainly presented with digestive system manifestations. The disorders of calcium and phosphorus metabolism occurred due to elevated PTH in this patient with parathyroid adenoma. After admission to hospital, diagnosis of hyperparathyroidism was established. As is well known, the most common cause of primary hyperparathyroidism is parathyroid adenoma (80%-85%)\[[@B4]\]. The parathyroid tumor was found by B-ultrasound, enhanced CT scan and 99 mTc-MIBI imaging. After treatment for decreased serum calcium, this patient was switched to surgery. Her serum calcium became normal after surgical treatment.

Multiple endocrine neoplasia 1 syndrome is an autosomal dominant disorder and includes parathyroid adenoma, pituitary tumor, gastrinoma, prolactinoma, insulinoma, bronchial carcinoid, and other endocrine tumors\[[@B5]\]. This endocrine tumor could occur in multiple organs and systems with both benign and malignant types\[[@B6]\]. The neoplasms derived from the parathyroid are usually benign, while many entero-pancreatic neuroendocrine tumors and foregut carcinoid tumors are malignant. Our patient had five tumors: Left parathyroid adenoma, right thyroid adenoma, uterine fibroids, right benign mammary gland tumors, and meningoma. The patient developed five tumors successively, is it a coincidence or is there a correlation among those five tumors?

Grinblat et al\[[@B7]\] reported a case in a depressed woman with both meningioma and parathyroid adenoma who attempted to commit suicide. In that case, the relationship between the parathyroid adenoma and meningioma was not clarified. Unlike that case, our patient was initially found to have a meningioma and had no functional endocrine gland tumors. The thyroid adenoma was confirmed histologically by right thyroid fine needle aspiration. Patients suffering from thyroid adenoma and concurrent parathyroid adenoma are rare, with most cases in the literature reporting concurrent hot thyroid nodule and primary hyperparathyroidism\[[@B8]\]. Since parathyroid adenoma can be located within the thyroid, it is particularly important to differentiate between thyroid adenoma and parathyroid adenoma.

Diseases of breast, uterus, and thyroid are common in women. Spinos et al\[[@B9]\] reported that women with uterine fibroids had an increased incidence of thyroid nodules and fibroadenomas of the breast. In addition, some researchers reported that thyroid nodules are associated with uterine fibroids and that estrogen might have a key role in occurrence of both uterine fibroids and thyroid nodules\[[@B10]\]. Audisio et al\[[@B11]\] also maintained that estrogen might be related to the occurrence of fibroadenoma growth. During hospitalization, our patient had a normal level of estrogen, but unfortunately, we were unable to acquire her estrogen data during her entire disease course. Whether estrogen played a role in those tumors remains uncertain.

CONCLUSION
==========

This case reported a middle-aged female who was found with multi-organ benign tumors. After surgical excision of some of these tumors, the patient recovered well. Of these tumors, the parathyroid adenoma was a hormone-secreting adenoma, and the underlying mechanisms may be revealed in future studies.
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